Cardea 20/20 ECG System

Insight that Can Save Lives

Cardea 20/20 is the first ECG system in the U.S. to incorporate breakthrough interpretive algorithms and the International Consensus Criteria, developed by 15 different medical and sports societies. These criteria provide Healthcare Practitioners with a standardized guide to quickly and accurately identify difficult-to-diagnose cardiac abnormalities that can lead to Sudden Cardiac Arrest (SCA) and Sudden Cardiac Death (SCD) in athletes.

By leveraging these internationally recognized guidelines, Cardea 20/20 enhances the evaluation process, ensuring more precise diagnoses and improved clinical decision-making for at-risk individuals. Cardea 20/20 is also being used by college conferences and professional sports teams!

Benefits:

• Lowest False Positives: ~2% versus the industry norm of up to 30% eliminates needless delays and anxiety from undue side-lining of athletes.
• Makes Cardiac Testing More Affordable: Low false positive rate avoids unnecessary and costly follow up testing.
• Better Analysis with High-Quality ECG Data: 16-second recording (vs. 10s standard) enables high-quality median beat computation, crucial for athletes with low resting heart rates.
• Faster Turnaround: On-site testing that analyzes ECG, provides diagnostics and flags high-risk conditions for further evaluation.
• Portable: An easily transportable lightweight ECG transmitter connects to a standard Windows PC via USB cable.
• Collaborative: Cloud storage compatible, making it easy to share ECG reports.
• Clinical Screening Compliance for AHA: Incorporated specific American Heart Association screening questions.
• 1-Year Comprehensive Warranty Coverage: Cardea 20/20 is backed by a warranty that can repair or replace the system as needed.